Stocks and Investing
Stocks and Investing
Thu, May 11, 2017
[ 08:45 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 04:45 AM ] - WOPRAI
[ 04:45 AM ] - WOPRAI
[ 04:45 AM ] - WOPRAI
[ 01:46 AM ] - WOPRAI
[ 01:46 AM ] - WOPRAI
[ 01:45 AM ] - WOPRAI
[ 01:45 AM ] - WOPRAI
[ 01:45 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jessica Fye Initiated (ASND) at Buy and Held Target at $36 on, May 11th, 2017
Jessica Fye of JP Morgan, Initiated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $36 on, May 11th, 2017.
Jessica has made no other calls on ASND in the last 4 months.
There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Jessica's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Joseph Schwartz of "Leerink Swann" Downgraded from Buy to Hold and Increased Target to $30 on, Thursday, March 9th, 2017
These are the ratings of the 2 analyists that currently disagree with Jessica
- Liana Moussatos of "Wedbush" Reiterated at Buy with Increased Target to $34 on, Friday, March 24th, 2017
- Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $28 on, Thursday, February 9th, 2017